PM Abbott Laboratories (ABT) and AstraZeneca plc (AZN) confirmed that they would advance the development of Abbott's next-generation fenofibrate ABT-335 and AstraZeneca's Crestor or rosuvastatin calcium in a fixed-dose combination treatment into Phase.Abbott And AstraZeneca To Advance Trial Of Combo Cholesterol Pill [ABT]
<< Home